Alok joined HSBC Private Equity in 2008, which has been renamed as Headland Capital Partners further to the management buyout in 2010. He is based at Mumbai as a member of the venture investment team.

Alok commenced his career at ANZ Grindlays Bank as part of the Investment Banking team responsible for Indian structured finance and syndications. He also worked with ABN AMRO Securities at the Debt Capital Markets desk.

In 2000, he joined Rabo India Finance (a part of the Rabobank Group) as a member of the life sciences and healthcare team and thereafter as part of the start-up team at YES Bank, commenced and developed the life sciences and technology practice. He has worked with a number of companies in these sectors on debt, equity capital raising and business and financial advisory services.

Alok holds an engineering and economics degree from the Birla Institute of Technology and Science, Pilani and an MBA from the Indian Institute of Management, Calcutta. He is also a member of the CII National Committee on Drugs & Pharmaceuticals and Biotechnology.

Ms. Shah has evolved Metropolis from its single pathology laboratory status to a fully integrated multinational chain of 125 diagnostic centers and 800 collection centers across the globe including UAE, South Africa, Mauritius and Ghana.

Ms. Shah is an eminent industry spokesperson and has been featured as a speaker at various National and International forums such as TedEX, Harvard Business School, CII (Confederation of Indian Industry),  IIM (Indian Institute of Management) - Ahmedabad and many such reputed institutions. She has also been elected the Secretary of the IAPL (Indian Association of Pathology Laboratories) and is the Chairperson of the ‘FICCI Health services Western Subgroup’ that drives policy decisions at the Center.

@AmeeraShah

Amit is the Head - Healthcare & Pharma, IT/ITES & Education Investments at Baring Private Equity Partners India and handles investment opportunities and portfolio companies in these respective sectors. He is also a Director on the Board of Sphaera Pharma - an integrated drug discovery and development company. He has worked in financial and business advisory in the past with leading Indian and Multinational companies. As part of the business consulting team at Accenture in India, he has advised clients on leveraging IT for business effectiveness and assisted clients in all change management issues associated with a large technology implementation.

Prior to working with Accenture, he was with the world's fourth largest and India's most influential credit rating agency, CRISIL, where he was involved in advising private and public sector clients on divestments, financial reviews and operational benchmarking. He is a recipient of the Directors Silver Medal from Indian Institute of Technology, Delhi where he graduated in Structural Engineering and a Post-Graduate Diploma in Management (MBA) from Indian Institute of Management, Lucknow. At Baring India Amit also leads the Corporate Communication & Public Relations initiatives of the firm.

Amit joined IVFA in 2008 and is based in Mumbai.

Amit has been involved in evaluating and executing IVFA’s investments in the healthcare services, manufacturing and infrastructure related businesses. Amit has also contributed towards development of the firm’s framework for evaluating exit opportunities for portfolio companies.

Amit has worked for six years with DSP Merrill Lynch in Mumbai in their M&A and private equity group and for three years with Deutsche Bank in Singapore as part of investment banking team. He was involved in raising capital and M&A in telecom, healthcare, financial services, IT, internet, infrastructure, manufacturing in and outside India.

Amit holds a Bachelor’s degree in Commerce and is a qualified Chartered Accountant.

Mr.Anjan Bose, Senior Director, Medical Systems, Indian Subcontinent, Philips Electronics India Ltd. He started his career as a Service Engineer with Philips Medical 30 years back and has been in various important functions within Healthcare industry since then. An Electronics & Electrical Communications Engineer from Indian Institute of Technology (IIT), Mr.Bose's work experience goes beyond India. He has worked in Europe as Regional Manager, in the Philips Headquarters in Holland and also led organisations like Hewlett-Packard Medical in South Asia and Emerging Markets in Asia. He has played significant leadership roles in developing symbiotic commitment to partnership between Trade, Industry and Healthcare Deliverers. He has successfully participated in many leadership/management programs over the years including the one from Michigan University. Mr. Bose is also a Council Member of the European Business Group.

Mr. Ashutosh Garg is an MBA and has worked in the corporate sector for twenty-five years. He spent seventeen years of his career at ITC Limited, where he rose to become the youngest ever managing director of any ITC group company. In January 1995, he was recognized as the &lsquoGlobal Leader for Tomorrow by the World Economic Forum at Davos, Switzerland. He left ITC the same year and spent eight years in the aerospace industry. In 2003 he started the chain of health and beauty retail outlets in north India under the brand name Guardian Pharmacy, which has now grown to over 117 outlets. He is also the author of the bestselling book &lsquoThe Buck Stops Here.

Mr. Garg is the member of the Young President Organisation since 1994 as well as a charter member of TiE (The Indus Entrepreneurs). He serves on the board of the Global Alliance for Vaccines and Immunization and several companies.

Dr Amit Varma currently operates as President Health Care, Religare Enterprises and Director, Critical Care Medicine, Fortis Escorts group of Hospitals, India. Having completed his MBBS and MD from University of Delhi, Dr Varma further completed his residency from the State University of New York. Thereafter he went on to pursue fellowships in critical care at the University of Pittsburgh Medical Center, and sub specialized in cardiac critical care at the Cleveland Clinic. Alongside this, he also attended courses for an Executive MBA at the University of Chicago.

After almost a decade in USA, Dr Varma began his professional journey in India at the Manipal Heart Foundation in Bangalore. He subsequently moved on to the Narayan Hrudayalaya Hospital as the consultant- in-charge of Critical Care. Early in 2003, Dr Varma joined Fortis Healthcare, where he has and continues to perform multiple administrative and clinical roles. He currently runs the integrated critical care services for Fortis Healthcare ICU network, which today comprises of a strong three-Hundred beds and helps in ormulation of Medical Strategy.

At Religare from 2009, Dr Varma is actively engaged in all healthcare initiatives of the company, playing an advisory and steering role, overlooking and further initiating all healthcare related businesses, providing medical expertise, insight and credibility in all healthcare related verticals such as Health Insurance venture, Healthcare IT, Super Religare Labs and Religare Wellness. He also sits on the Board and Investment committee of the 125$ million Milestone Religare Private Equity fund which is investing domestically in the healthcare and education fields.

Dr. Khanduja Chairman and Managing Director BSR Healthcare is a career Pediatrician of twenty five years experience and ventured to become an entrepreneur sixteen years back. BSR Healthcare runs 8 high end Diagnostic centers across Chhattisgarh, Maharashtra and West Bengal. And 175 bedded “Apollo BSR Hospitals” located at Bhilai. Group aims to expand BSR healthcare as a chain of hospitals and diagnostic center on a pan - India level. BSR is presently expanding in medical diagnostic with another 10 centers as well as hospital business by way of two Specialty Hospitals.

Dr Mahipal. S. Sachdev, Chairman  & Medical Director of Centre For Sight was honored with Padmashri award on January 26, 2007. He is a renowned ophthalmic Surgeon who is recognized for his expertise in the area of Corneal, Refractive & Cataract Surgery, both nationally and internationally.

Dr. Sachdev completed his MBBS from the All India Institute of Medical Sciences. He pursued MD in Ophthalmology at Dr Rajendra Prasad Center for Ophthalmic Sciences. He did advanced training and fellowship in Cornea at the Georgetown University, Washington, USA. He has received training in Refractive Surgery and Phacoemulsification. Dr. Sachdev has been Secretary of the Delhi Ophthalmological Society (DOS) and the Chairman, Scientific Committee of All India Ophthalmological Society (AIOS). Currently he is the Chairman Intraocular implant and Refractive Society, India.

Dr Mahipal S. Sachdev has received numerous awards and distinctions in India and abroad for his contribution to Ophthalmology. He has been recognized globally with fellowships and scholarships from the “Fifth International Symposium on Immunopathology”- Japan, “International Society of Eye Research”, “Research to Prevent Blindness”, New York, “Fisons award by the Contact Lens Association of Ophthalmologists”, USA amongst others.

Dr. O.P. Manchanda is the Chief Executive Officer of Dr. Lal PathLabs Pvt. Ltd, India's state-of-the-art laboratory service provider chain. He has about 20 years of sales, marketing & general management exposure in diverse business sectors like Fast Moving Consumer Goods (FMCG), agri-biotech space, consumer healthcare and medical diagnostics.  

Before joining Dr. Lal PathLabs Pvt. Ltd in the year 2005, Dr. Manchanda led the International & Innovation group of the Consumer Healthcare Division at Ranbaxy, India's largest pharmaceutical company. He was part of the team that launched Ranbaxy's foray into consumer healthcare.

Prior to joining Ranbaxy, Dr. Manchanda worked for Monsanto and Hindustan Unilever. At Monsanto, he was part of the team that successfully launched their first ever biotech product Bt-Cotton as the head of Sales and Marketing.

During his tenure with Hindustan Unilever for about 10 years, he received in-depth exposure in consumer products sales, distribution and marketing. He has also received in-depth exposure in Innovation Process Management as he was the first brand manager with Beverages Innovation Group. He successfully led the concept cum product development, and the market launch of Lipton Tiger A Tea Based Beverage, the first ever innovation product from the Beverages Innovations Group in the year 1998. At Unilever, he received several awards including the Chairman's Global Best Innovation Award for Lipton Tiger.

Dr. O.P. Manchanda has done MBA from the Indian Institute of Management, Ahmedabad (IIM Ahmedabad).

Dr. Rana Mehta currently leads the Healthcare Advisory at PricewaterhouseCoopers (PwC) He has over 15 years of experience in strategizing, planning, commissioning and operations of over 50 hospitals in South Asia. He has developed customized healthcare solutions to suit client needs within political, socio economic, geographic, and demographic imperatives.

Dr. Mehta also worked for  the Apollo Hospitals Group, Asia’s largest private healthcare provider He has been instrumental in commissioning and operating the Group’s hospitals in Delhi and Colombo.

Educational Profile
Master of Hospital Administration (MHA), Tata Institute of Social Sciences, Mumbai, India.
Bachelor of Medicine, Bachelor of Surgery (MBBS), Medical College, Kolkata, India.

Dr. Sanjeev K Chaudhry is an accomplished management professional, author and researcher. He is presently Managing Director of SRL Limited and Chairman of CSC Nutrigenomics Pte Limited, Singapore. He also serves on the Board of Directors of several companies and institutions in India and abroad.

SRL Limited is India’s largest and world’s leading Healthcare Diagnostics Company. The company runs a network of 250 Pathology Laboratories and Radiology Centers in India and serves over ten million people annually.

He was the South Asia head of DuPont Solae until June 2006, a position he held for eleven years. Prior to that he served as Chairman & Managing Director of Modern Food Industries and was the youngest person to head a Government of India company. He was also the first CEO of NatOleo Sdn Bhd Malaysia one of world’s largest producers of Oleochemicals.

He has a Ph.D in Business Administration from Columbia University, United States and holds a university record for Masters in Economics at Punjab University, Chandigarh.

Dr. Sanuj K. Ravindran -Dr. Ravindran is the Managing Director of Asian Healthcare Fund (AHF), a New Delhi based PE/VC fund that invests in growth-stage healthcare and life sciences companies, primarily in India and Southeast Asia. Previously, Dr. Ravindran was a Principal of Radius Ventures, a venture capital firm focused on leading-edge health and life sciences companies; and prior to Radius, he was a Director of Burrill & Company’s venture capital group, where he also founded and led the Burrill India Group. In addition to his role with AHF, Dr. Ravindran currently serves on the Boards of Chennai based RxMD and Florida based Gyrx.  

Dr. Ravindran’s prior board roles include Ambit Biosciences, Athersys, Resolvyx Pharmaceuticals, Endocyte, Proventys and diaDexus.  He is a member of the Society of Kauffman Fellows and is a U.S. Board Certified physician (Internal Medicine).  Dr. Ravindran received his B.A. from Northwestern University, his M.D. from Jefferson Medical College and his M.B.A. from the Kellogg School of Management, where he was a Rothschild Scholar.

Mr. Gopalakrishna sees BD as a platform to ensure that good quality healthcare is available to the Indian population at affordable prices.

An alumnus of Wharton School and Georgetown School of Business, Manoj Gopalakrishna started his career with Hindustan Latex, where he was involved with the marketing operations of the company. While at Hindustan Latex, Mr. Gopalakrishna partnered with BD on injection safety issues, especially in syringes and admired the company for its values and mission, which led him to join it in 2009.

Mr. Gopalakrishna has almost two decades of experience in the healthcare sector in India mainly revolving around building and executing public-private partnerships. Under his leadership, Becton Dickinson is now closely working with the government for good clinical practices as part of the business strategy. Mr. Gopalakrishna is committed to aid the growth of BD in the Indian market by enhancing partnerships and relationships.

Mr. Gopalakrishna sees BD as a platform to ensure that good quality healthcare is available to the billion plus Indian population at affordable prices.

BD operates in India through a wholly-owned subsidiary, BD India Pvt. Ltd. BD has a manufacturing facility in India, a highly automated plant at Bawal, Haryana. This facility produces products recognized around the world, including disposable needles, syringes and catheters.

After pursuing his Masters in Science from Northwestern University USA, Mayur Abhaya, the young businessman, decided to take charge of Shasun business which was established a few decades ago. He started his assignment with Shasun in handling Information Security Management and on successful implementation of this he moved on the next layer of automation in leading the ERP implementation. Though he had a science background in his education his outlook always had strong traits of strategic business management, business automation, systems and processes needed for a professional organizational management. His education along with this skill helped Mayur in getting into strategic core areas in Shasun like Intellectual Property Rights, Licensing, new product development etc where contributed to a great extent.

After setting quality & process standards at Shasun, Mayur was invited by the board of management of LifeCell to take charge as Executive Director of LifeCell International. Mayur is now actively involved in driving the business in total perspective from banking, research to therapy. He has set himself on an ambitious track of putting LifeCell in the international map of stem cell technology and positioning LifeCell as the hub for stem cell solutions worldwide.

Naveen heads the Indian operations of TA Associates Advisory Pvt Ltd, focusing on investments in growth companies in India and other emerging markets. He is a member of the Board of Directors of Dr Lal PathLabs and Micromax. Previously, while with TA Associates in Boston and London, Naveen played a significant role in the firm’s investments in Drive Assist, GlobeOp Financial Services, ION Trading, SmartStream Technologies and 2nd Story Software. Prior to joining TA in 2001, Naveen worked in the Mergers and Acquisitions Group at Broadview International. He also worked as a member of the Asian Special Situations Group at Goldman, Sachs & Co and at Accretive LLC. Naveen received a BSc in Systems Engineering from the University of Pennsylvania, and an MBA from the Wharton School of Finance.

Over 23 years of experience in managing large businesses in the financial services industry. Invested and created liquidity for over US$ 500 m of investments.

Led the US$ 229 m recapitalization and restructuring by Sabre Group of Centurion Bank and set up an asset management business - Lotus India, as a JV with Temasek Holdings.

Led businesses in Asia with Citibank, Goldman Sachs & JP Morgan. Former Global Head of Private Equity, & E-commerce for Standard Chartered Bank.

MBA from IIM, Bangalore and Bachelor of Engineering from BITS, Pilani.

Ratan Jalan founded Medium Healthcare Consulting in 2009 driven by an urge to ‘make a difference in healthcare’. Innovation in business models and patient empowerment have been at the core of what he does. Ratan has over three decades of experience across diverse industries and functional responsibilities. He started his professional career in the information technology industry with HCL Technologies and then moved to advertising at Lintas (now Lowe).

Earlier, Ratan was the CEO of Apollo Health and Lifestyle Limited, part of the Apollo Hospitals Group for almost a decade. He created some of the most successful and innovative healthcare formats in the country such as a nationwide network of The Apollo Clinic and The Cradle, South Asia’s first boutique birthing centres. In 1996, as President, Ratan set up India’s first hospital architecture and consulting firm Asian Health Services, a JV with ServiceMaster, a Fortune 500 company. He was awarded the Marketing Impact Award by S P Jain Institute of Management and has been nominated as one of the 50 most influential professionals in retailing. He is an alumnus of IIT Kharagpur and Harvard Business School.

Dr S Chandrakumar is a postgraduate doctor by profession with over 18 years of reputed clinical experience in managing patients and managing multi speciality hospitals.

He is a life member in Indian Medical Council and Indian Society of Anaesthesiologists. He was selected by the CII as one of the 101 best Entrepreneurs in Tamil Nadu for year 2008-09.

He has been selected for the young Turks of Trichy Award by Periyar Maniammai Trust headed by Sri.Veeramani for the year 2008-09.

He is the current Chairman Trichy CII zone- for the year 2011-12 and he is also Charter Chairman Trichy Kendra of Bharathiya Vidya Bhavan- a movemet for cultural renaissance across the country.

He is the founder and the Managing Director of Kavery group- multi-speciality hospitals which has a renowned brand value in and around Trichy and soon establishing in Chennai and Hosur.

He has been bestowed with “Vocational Excellence Award for the Rotary year 2010-11” by the Rotary club of Trichirapalli Rock city. He holds the membership of the Boards of many other health care companies.

Mr Mehta is the Director of the Atlas Family Office (Atlas Venturez multi-family offices) and Director of Dr Mehta’s Hospitals.  Sam participates on various national healthcare, education and investment association committees.  He sits on the board of a number of companies in Technology, Chemicals, Healthcare, Education and Media and is an advisor to a few funds. He is on the Executive Committee of the Chennai Angels.

Mr Mehta brings over 2 decades of enterprise leadership, multi-national operating, project management, governance, strategic consulting, investment management and entrepreneurial experience within leading organizations like McKinsey & Company, Shell and Fortune 10 and Family Business companies across multiple sectors (healthcare, education, energy, chemicals, technology and retail) across Asia, Europe, Latin and North America. He was a former venture advisor with TVS Capital and election observer with the OSCE/UN.

Mr Mehta has an MBA from the Kellogg School of Management, a Masters in Manufacturing Engineering Management and Masters in Chemical Engineering.  Mr Mehta is a Chartered Chemical Engineer (CEng) with the Institute of Chemical Engineers, a Professional European Engineer (EUR ING) with FEANI, a Chartered Scientist (CSci) with the Science Council, a Chartered Environmentalist (CEnv) with the Society for the Environment and a Sainsbury Management Fellow (SMF) with the Royal Academy of Engineering, UK.

Sudhir is an Engineer from IIT Mumbai and MBA from IIM Lucknow with over 19 years of experience in private equity, banking and KPO. He is based in New Delhi and is responsible for Business Development and closing of deals for several verticals in Northern Region, Brand Capital.

He has worked with SIDBI and ICICI in Project Finance and Credit Risk Management functions. Thereafter he worked with a European investment fund, being responsible for the Fund’s investments in India and other emerging markets.

Sudhir has also worked with Genpact, Gurgaon, a leading provider of outsourcing services, where he was leading delivery of Analytics services to global clients in the Private Equity, Banking, and Equipment Finance space.

Sudhir loves travelling, reading and watching movies in his spare time.

Dr. Sunny Sharma is a Senior Managing Director on the Asia team of OrbiMed Advisors. Dr. Sharma has more than 10 years of life sciences experience spanning venture capital, investment banking, and clinical practice.

Dr. Sharma was previously with Investor Growth Capital (IGC), the wholly owned global venture capital arm of Investor AB, and before that he was at Easton Capital, a venture capital fund in New York. While at IGC and Easton Capital, Dr. Sharma led or played a senior role on over a dozen life sciences investments. Earlier in his career, Dr. Sharma was with Lehman Brothers' healthcare investment banking group in London, and before that he practiced medicine in northern India.

Dr. Sharma holds an M.B.A. from Indian Institute of Management, Bangalore and a medical degree (M.B.B.S.) from Christian Medical College, Ludhiana where he was awarded the Vipin Khanna Memorial Gold Medal for graduating as the best intern.